This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Anderson, K. P. Articles by Moddrelle, D. Search for Related Content PubMed PubMed Citation Articles by Anderson, K. P. Articles by Moddrelle, D.

Circulation, Vol 81, 1024-1038, Copyright © 1990 by American Heart Association

ARTICLES

Conduction velocity depression and drug-induced ventricular tachyarrhythmias. Effects of lidocaine in the intact canine heart

KP Anderson, R Walker, RL Lux, PR Ershler, R Menlove, MR Williams, R Krall and D Moddrelle
Cardiology Division, University of Utah Medical Center, Salt Lake City 84132.

Depression of myocardial conduction velocity can be an important mechanism of action of antiarrhythmic drugs but it can also facilitate arrhythmogenesis. We used lidocaine in an anesthetized canine preparation to address the hypothesis that drug-induced rate-dependent conduction velocity depression causes ventricular tachyarrhythmias. A closely spaced square array of 64 electrodes was used to determine conduction velocity longitudinal and transverse to epicardial ventricular fiber direction. Lidocaine caused rate-dependent decreases in conduction velocity that were proportionately greater in the longitudinal direction at the shortest pacing cycle lengths. Conduction velocity depression developed rapidly in the presence of lidocaine with a new steady state present by the second beat of the rapid train. Recovery from rate-dependent depression of conduction velocity was exponential with a time constant of 122 +/- 20 msec (mean +/- SD) in the longitudinal direction and 114 +/- 30 msec in the transverse direction; this difference was not significant. The relation between conduction velocity depression and ventricular arrhythmias was assessed by pacing for 3 minutes at cycle lengths of 1,000, 500, 300, and 250 msec, and for 1 minute at a cycle length of 200 msec. Arrhythmias did not occur in the baseline period in the dogs that received lidocaine, nor in 12 control dogs that were subjected to the same stimulation protocol except that saline was administered in place of lidocaine. Sustained polymorphic ventricular tachycardia (VT) occurred in six of 16 dogs given lidocaine. VT occurred in the presence of relatively high plasma lidocaine concentrations (8.4 +/- 2.3 micrograms/ml) and only at pacing cycle lengths of 300 msec or shorter. The dogs that developed VT demonstrated greater rate-dependent depression of conduction velocity than the other dogs, and activation patterns obtained just before the onset of VT showed marked conduction disturbances. Furthermore, QRS prolongation, loss of one-to-one capture, and increasingly distorted activation patterns preceded the onset of VT during fixed-rate pacing, suggesting progressive sodium channel block. In summary, rate-dependent conduction velocity depression and nonuniform activation were associated with VT in this model and can be responsible for some arrhythmias induced by antiarrhythmic drugs.

This article has been cited by other articles:

				T. Xue, H. C. Cho, F. G. Akar, S.-Y. Tsang, S. P. Jones, E. Marban, G. F. Tomaselli, and R. A. Li Functional Integration of Electrically Active Cardiac Derivatives From Genetically Engineered Human Embryonic Stem Cells With Quiescent Recipient Ventricular Cardiomyocytes: Insights Into the Development of Cell-Based Pacemakers Circulation, January 4, 2005; 111(1): 11 - 20. [Abstract] [Full Text] [PDF]

				J.-Y. Lefrant, J. E. de La Coussaye, J. Ripart, L. Muller, L. Lalourcey, P. A. Peray, X. Mazoit, A. Sassine, and J.-J. Eledjam The Comparative Electrophysiologic and Hemodynamic Effects of a Large Dose of Ropivacaine and Bupivacaine in Anesthetized and Ventilated Piglets Anesth. Analg., December 1, 2001; 93(6): 1598 - 1605. [Abstract] [Full Text] [PDF]

				M. S. Spach, J. F. Heidlage, P. C. Dolber, and R. C. Barr Extracellular Discontinuities in Cardiac Muscle : Evidence for Capillary Effects on the Action Potential Foot Circ. Res., November 30, 1998; 83(11): 1144 - 1164. [Abstract] [Full Text] [PDF]

				M. R. Ujhelyi, J. J. Sims, and A. W. Miller High-dose lidocaine does not affect defibrillation efficacy: implications for defibrillation mechanisms Am J Physiol Heart Circ Physiol, April 1, 1998; 274(4): H1113 - H1120. [Abstract] [Full Text] [PDF]

				A. P. Winecoff, J. J. Sims, M. L. Markel, and M. R. Ujhelyi Pinacidil's Effects on Defibrillation Outcomes: Role of Increased Potassium Conductance Via the KATP Channel Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1997; 2(3): 171 - 180. [Abstract] [PDF]

				S. Ranger and S. Nattel Determinants and Mechanisms of Flecainide-Induced Promotion of Ventricular Tachycardia in Anesthetized Dogs Circulation, September 1, 1995; 92(5): 1300 - 1311. [Abstract] [Full Text]

				M. Restivo, H. Yin, E. B. Caref, A. I. Patel, G. Ndrepepa, M. J. Avitable, M. A. Assadi, N. Isber, and N. El-Sherif Reentrant Arrhythmias in the Subacute Infarction Period : The Proarrhythmic Effect of Flecainide Acetate on Functional Reentrant Circuits Circulation, February 15, 1995; 91(4): 1236 - 1246. [Abstract] [Full Text]